This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leo E. Hollister, MD; Kenneth L. Davis, MD; Philip A. Berger, MD

Arch Gen Psychiatry. 1980;37(10):1107-1110.

Abstract
• We investigated the relationship between urinary excretion of MHPG and the clinical response of 17 depressed patients to nortriptyline hydrochloride. Plasma concentrations of nortriptyline were monitored to assure optimal doses. Patients were classified as having "low" or "normal-high" excretion of MHPG based on one to five 24-hour urine specimens. Hamilton Depression Rating Scale scores were not reduced significantly more among the nine low excreters as compared with the eight normal-high excreters. However, when a true bimodal distribution of MHPG excretion was created by comparing only the six lowest excreters with the six highest excreters, the low group improved significantly more than the high group. This differential response to nortriptyline somewhat supports the notion that MHPG excretion may predict response to specific tricyclics. Collecting urine for MHPG determination in depressed patients is not easy; the variability of excretion within patients is considerable, and the range of MHPG excretion closely parallels that in normal persons. The clinical utility of this procedure is still to be determined.

Author Affiliations
From the Stanford University School of Medicine, Stanford, Calif; and the Veterans Administration Hospital, Palo Alto, Calif.

Footnotes
Accepted for publication Dec 10, 1979.

Reprint requests to Veterans Administration Hospital, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Hollister).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

High Intercorrelations Among Urinary Outputs of Norepinephrine and Its Major Metabolites: A Replication in Depressed Patients and Controls
Roy et al.
Arch Gen Psychiatry 1988;45:158-161.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Catecholamine Metabolism and Disposition in Healthy and Depressed Subjects
Maas et al.
Arch Gen Psychiatry 1987;44:337-344.
ABSTRACT  

Selective Antidepressants and Cerebrospinal Fluid: Lack of Specificity on Norepinephrine and Serotonin Metabolites
Potter et al.
Arch Gen Psychiatry 1985;42:1171-1177.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

CSF and Urinary Biogenic Amines and Metabolites in Depression and Mania: A Controlled, Univariate Analysis
Koslow et al.
Arch Gen Psychiatry 1983;40:999-1010.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression
Charney et al.
Arch Gen Psychiatry 1981;38:1160-1180.
ABSTRACT